British scientists develop rapid genetic test to diagnose brain cancer

London: A groundbreaking rapid genetic test for brain tumors has been developed by British scientists, capable of identifying the specific type of tumor in under two hours. This swift diagnosis could significantly reduce patient wait times and facilitate earlier treatment initiation, according to the UK National Health Service (NHS).

The test, which analyzes a small tumor sample taken during biopsy or surgery, can deliver results even while the patient is still on the operating table, offering a potential breakthrough in brain tumor diagnosis.

Professor Frankie Swords, the NHS's medical director, highlighted the transformative impact of this technology. She stated that a faster diagnosis would enable patients to commence appropriate treatment or participate in clinical trials sooner, while also assisting surgeons in making critical decisions during surgery. The results may help surgeons determine the extent of tumor removal without harming healthy brain tissue, taking into account more detailed genomic information for crucial surgical decisions.

Each year, approximately 13,000 individuals in the UK are diagnosed with primary brain tumors, a condition that encompasses over 100 different types. These tumors vary in growth rates and responsiveness to treatment, necessitating precise identification for effective management. With this rapid genetic test, healthcare professionals could potentially provide more tailored and timely interventions, improving patient outcomes for those affected by brain tumors.